Agilon Health (NYSE:AGL) Reaches New 12-Month High – Time to Buy?

Agilon Health, Inc. (NYSE:AGL)’s stock price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as $119.25 and last traded at $117.7050, with a volume of 554 shares traded. The stock had previously closed at $119.25.

Analyst Ratings Changes

Several equities research analysts have recently commented on AGL shares. Deutsche Bank Aktiengesellschaft raised Agilon Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $33.00 to $49.00 in a research note on Thursday, May 7th. JPMorgan Chase & Co. lowered Agilon Health from a “neutral” rating to an “underweight” rating and set a $21.00 price target on the stock. in a research note on Monday, May 4th. Benchmark reiterated a “buy” rating and issued a $95.00 price target (up from $13.00) on shares of Agilon Health in a report on Thursday, May 21st. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research report on Saturday, May 9th. Finally, Barclays raised Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price objective for the company in a report on Tuesday, May 26th. Five equities research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Agilon Health currently has an average rating of “Hold” and a consensus price target of $58.73.

Agilon Health Stock Up 2.3%

The firm’s 50-day simple moving average is $75.82 and its 200 day simple moving average is $37.44. The company has a market cap of $2.04 billion, a P/E ratio of -5.69 and a beta of 3.00. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.04 and a current ratio of 1.04.

Agilon Health (NYSE:AGL) last posted its quarterly earnings results on Wednesday, May 6th. The company reported $1.80 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.04 by $0.76. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%.The business had revenue of $1.42 billion for the quarter, compared to analyst estimates of $1.38 billion. On average, research analysts forecast that Agilon Health, Inc. will post -3.5 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Alpine Global Management LLC acquired a new position in shares of Agilon Health during the 4th quarter worth about $84,000. Focus Partners Advisor Solutions LLC acquired a new stake in shares of Agilon Health in the 4th quarter valued at approximately $53,000. CIBC Bancorp USA Inc. acquired a new stake in shares of Agilon Health in the 3rd quarter valued at approximately $34,000. LPL Financial LLC boosted its stake in Agilon Health by 213.4% during the 4th quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after acquiring an additional 30,000 shares during the last quarter. Finally, North Peak Capital Management LLC boosted its stake in Agilon Health by 10.8% during the 4th quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock worth $26,267,000 after acquiring an additional 3,715,460 shares during the last quarter.

Agilon Health Company Profile

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.